Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
21 December 2023 - 11:30PM
Business Wire
Organon (NYSE: OGN), announced today that Kevin Ali, Chief
Executive Officer, and Matthew Walsh, Chief Financial Officer, are
scheduled to participate in a fireside chat at the 42nd Annual J.P.
Morgan Healthcare Conference on Tuesday, January 9th, 2024, at 1:30
p.m. PT.
Investors, analysts, members of the media and the general public
are invited to listen to a live audio webcast of the presentation
at:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49500-organon/webcast?gpu_only=true&kiosk=true
About Organon Organon is a global healthcare company
formed to focus on improving the health of women throughout their
lives. Organon offers more than 60 medicines and products in
women’s health in addition to a growing biosimilars business and a
large franchise of established medicines across a range of
therapeutic areas. Organon’s existing products produce strong cash
flows that support investments in innovation and future growth
opportunities in women’s health and biosimilars. In addition,
Organon is pursuing opportunities to collaborate with
biopharmaceutical innovators looking to commercialize their
products by leveraging its scale and presence in fast growing
international markets.
Organon has a global footprint with significant scale and
geographic reach, world-class commercial capabilities, and
approximately 10,000 employees with headquarters located in Jersey
City, New Jersey.
For more information, visit http://www.organon.com and connect
with us on LinkedIn, Instagram, X (formally known as Twitter) and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231221445274/en/
Media:
Karissa Peer (614) 314-8094
Kate Vossen (732) 675-8448
Investor:
Jennifer Halchak (201) 275-2711
Alex Arzeno (646) 430-2028
Organon (NYSE:OGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organon (NYSE:OGN)
Historical Stock Chart
From Sep 2023 to Sep 2024